Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 Seroprevalence”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableUnknownNCT04446338
What this trial is testing

Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre

Who this might be right for
History of Covid-19, Seroprevalence
University Hospital Tuebingen 300
Not applicableWithdrawnNCT04594395
What this trial is testing

Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT04630054
What this trial is testing

Face Masks to Reduce COVID-19 in Bangladesh

Who this might be right for
Covid19
Yale University 350,000
Not applicableStudy completedNCT04517097
What this trial is testing

Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic

Who this might be right for
Cancer
Centre Georges Francois Leclerc 1,680
Not applicableStudy completedNCT04647305
What this trial is testing

Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission

Who this might be right for
SARS-CoV-2 Infection
University of Los Andes, Columbia 233
Not applicableStudy completedNCT04441684
What this trial is testing

Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)

Who this might be right for
SARS-CoV-2 Serological StatusSARS-CoV-2 Seroprevalence
University Hospital, Strasbourg, France 1,466
Not applicableStudy completedNCT04516928
What this trial is testing

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel

Who this might be right for
SARS-CoV InfectionCovid19
Direction Centrale du Service de Santé des Armées 392
Not applicableStudy completedNCT04490850
What this trial is testing

COVID-19 Seroprevalence Study in French Guiana

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory SyndromeSARS-CoV Infection+1 more
Institut Pasteur 3,541
Not applicableStudy completedNCT04416308
What this trial is testing

COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)

Who this might be right for
Coronavirus
Rennes University Hospital 9,453
Not applicableStudy completedNCT04355533
What this trial is testing

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Who this might be right for
COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 1,056
Not applicableStudy completedNCT04533360
What this trial is testing

Prevalence of COVID-19 Antibodies Kingman AZ

Who this might be right for
Covid19
Kingman Regional Medical Center 566
Not applicableStudy completedNCT04442087
What this trial is testing

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP

Who this might be right for
SARS-CoV2
Assistance Publique - Hôpitaux de Paris 563
Not applicableStudy completedNCT07021807
What this trial is testing

ANC COVID-19 Surveillance

Who this might be right for
SARS-CoV-2 Seroprevalence
Centre for Infectious Disease Research in Zambia 9,111
Not applicableUnknownNCT04345315
What this trial is testing

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Who this might be right for
COVID-19SARS-CoV-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500
Not applicableStudy completedNCT04413968
What this trial is testing

COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants

Who this might be right for
CoronavirusCoronavirus InfectionCovid19+1 more
Assistance Publique - Hôpitaux de Paris 600
Not applicableStudy completedNCT04893057
What this trial is testing

COVID-19 Seroprevalence in Pregnant Women and Blood Donors

Who this might be right for
COVID-19 Respiratory Infection
Centre Hospitalier Universitaire de Besancon 797
Not applicableUnknownNCT04595175
What this trial is testing

Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)

Who this might be right for
COVID-19 Infection
Brian Tiffany, MD 2,000
Not applicableStudy completedNCT04874740
What this trial is testing

Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region

Who this might be right for
COVID-19 PandemicTransplantation, Kidney
University Hospital Ostrava 300
Not applicableStudy completedNCT04383587
What this trial is testing

Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers

Who this might be right for
SARS-CoV 2COVID-19
Mayo Clinic 300
Not applicableStudy completedNCT04448769
What this trial is testing

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)

Who this might be right for
Coronavirus InfectionPrevalence
Central Hospital, Nancy, France 2,006
Next Page